A Randomized Phase 2b Trial Examined the Effects of the Glucagon-Like Peptide-1 and Glucagon Receptor Agonist Cotadutide on Kidney Outcomes in Patients with Diabetic Kidney DiseaseViknesh Selvarajah,Darren Robertson,Lars Hansen,Lutz Jermutus, Kirsten Smith, Angela Coggi,Yi-Ting Chang,Jose Sanchez,Hongtao Yu,Joanna Parkinson,Anis Khan, H. Sophia Chung,Sonja Hess, Richard Dumas, Tabbatha Duck, Simran Jolly, Tom G. Elliott,John Baker,Albert Lecube, Carl Peters, Karl-Michael Derwahl, Russell Scott,Cristobal Morales,Ronald Goldenberg,Victoria E. R. Parker,Hiddo J. L. HeerspinkKIDNEY INTERNATIONAL（2024）引用 0|浏览4关键词chronic kidney disease,cotadutide,diabetic kidney disease,type 2 diabetes mellitusAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
